Aptevo Therapeutics Inc (NASDAQ:APVO) has a beta value of 5.05 and has seen 0.72 million shares traded in the recent trading session. The APVO stock price is -3383.87% off its 52-week high price of $10.80 and 54.84% above the 52-week low of $0.14. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.68 million shares traded. The 3-month trading volume is 6.64 million shares.
Aptevo Therapeutics Inc (NASDAQ:APVO) trade information
Sporting 0.84% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the APVO stock price touched $0.31 or saw a rise of 6.0%. Year-to-date, Aptevo Therapeutics Inc shares have moved -96.10%, while the 5-day performance has seen it change 43.86%. Over the past 30 days, the shares of Aptevo Therapeutics Inc (NASDAQ:APVO) have changed 26.55%. Short interest in the company has seen 1.2 million shares shorted with days to cover at 0.09.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aptevo Therapeutics Inc (APVO) estimates and forecasts
Figures show that Aptevo Therapeutics Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -57.43% over the past 6 months, with this year growth rate of 95.86%, compared to 18.00% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 46.80% over the past 5 years.
APVO Dividends
Aptevo Therapeutics Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Aptevo Therapeutics Inc (NASDAQ:APVO)’s Major holders
Insiders own 0.03% of the company shares, while shares held by institutions stand at 6.93% with a share float percentage of 6.94%. Investors are also buoyed by the number of investors in a company, with Aptevo Therapeutics Inc having a total of 20.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. As of Sep 30, 2024, the former fund manager holds about 0.24% shares in the company for having 43.68 shares of worth $13935.0 while later fund manager owns 2.08 shares of worth $664.0 as of Jun 30, 2024, which makes it owner of about 0.01% of company’s outstanding stock.
